Sixth Wave Innovations Inc. is pleased to announce the appointment of Sokhie Puar to its Board of Directors.Mr. Puar, with over 30 years in the public markets, has worked in various capacities in both public and private companies in a variety of sectors, including mining, oil and gas, technology, education and clean energy. Most recently, Mr. Puar held the positions of CEO, Chairman and Director of Candelaria Mining ...

Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: ATURF) (FSE: AHUH) ("Sixth Wave", or the "Company") is pleased to announce the appointment of Sokhie Puar to its Board of Directors.

Mr. Puar, with over 30 years in the public markets, has worked in various capacities in both public and private companies in a variety of sectors, including mining, oil and gas, technology, education and clean energy. Most recently, Mr. Puar held the positions of CEO, Chairman and Director of Candelaria Mining Corp. from February 2012 to September 2017. During his tenure, Candelaria Mining Corp. raised in excess of $28 million and acquired several mining projects in Mexico. Mr. Puar is currently the Lead Director of Else Nutrition Holdings Inc., a company which he helped go public. Since going public in June of 2019, Else Nutrition has raised over $41 million. Mr. Puar also sits on the board of Adcore Inc., a technology company in the digital advertising space.

Mr. Puar holds a diploma in Mechanical Engineering Technology and a diploma in Business Administration from the British Columbia Institute of Technology. Mr. Puar sits and has sat on the board of many public and private companies including the board of Governors of Southpointe Academy, an independent school located in Tsawwassen, B.C., where he Chaired the Governance Committee, and currently sits on multiple committees including Vice Chair of the Executive Committee.

"We are thrilled to have Mr. Puar join Board," noted Dr. Jon Gluckman, President & CEO of Sixth Wave. "Sokhie brings a depth of business experience that will be invaluable as we progress the various opportunities currently under development."

The Company further reports that it has granted a total of 500,000 options to directors of the Company. The options are exercisable at $0.46 per share and will expire on March 15, 2026. One third of the options will vest after six months, with an additional third vesting every six months thereafter until fully vested.

About Sixth Wave

Sixth Wave is a nanotechnology company with patented technologies that focus on extraction and detection of target substances at the molecular level using highly specialized Molecularly Imprinted Polymers (MIPs). The Company is in the process of a commercial rollout of its Affinity™ cannabinoid purification system, as well as, IXOS®, a line of extraction polymers for the gold mining industry. The Company is in the development stages of a rapid diagnostic test for viruses under the Accelerated MIPs (AMIPs™) label.

Sixth Wave can design, develop and commercialize MIP solutions across a broad spectrum of industries. The Company is focused on nanotechnology architectures that are highly relevant for the detection and separation of viruses, biogenic amines, and other pathogens, for which the Company has products at various stages of development.

For more information about Sixth Wave, please visit our web site at: www.sixthwave.com.

ON BEHALF OF THE BOARD OF DIRECTORS

"Jonathan Gluckman"
Jonathan Gluckman, Ph.D., President & CEO

For information, please contact the Company:
Phone: (801) 582-0559
E-mail: info@sixthwave.com

Cautionary Notes

This press release includes certain statements that may be deemed "forward-looking statements". All statements in this release, other than statements of historical facts, that address future events or developments that the Company expects, are forward-looking statements. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance, and actual events or developments may differ materially from those in forward-looking statements. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause the Company's actual performance and financial results in future periods to differ materially from any projections of future performance or results expressed or implied by such forward-looking statements.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/77286

News Provided by Newsfile via QuoteMedia

Sixth Wave On-Site Performance Testing of Affinity System

Sixth Wave On-Site Performance Testing of Affinity System

Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) ("Sixth Wave", "SIXW" or the "Company") is pleased to provide an update on commercial deployment of the Affinity™ System (the "System") for purification of cannabinoids. Green Envy Extracts (customer) will ramp up its production line in Michigan on or about December 15, 2021. Once production commences, SIXW will use the crude extract to complete performance testing on the Affinity System. Testing will occur three weeks earlier than initially planned. SIXW has also completed the manufacture of Affinity™ nano-tech beads for use in the full-size production Affinity™ System scheduled for installation in Michigan. By year-end, SIXW will manufacture three additional bead orders that are slated to complete four production Affinity™ Systems.

"We are very pleased to continue our collaboration with Sixth Wave on the launch of the Affinity™ system," states Amato Spagnoletti, [Director] of Green Envy. "As a growing multi-state cannabis operator, we believe that our respective technological approaches will yield significant technical and commercial benefits as we commission the first Affinity system with Sixth Wave in Michigan. Per our signed MOU, we plan to purchase a minimum of 3 Affinity™ units for placement at additional locations in the coming months," he added.

Keep reading... Show less
Sixth Wave and York University Co-Develop a Fluorometric Microfluidic AMIPs Device

Sixth Wave and York University Co-Develop a Fluorometric Microfluidic AMIPs Device

Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) ("Sixth Wave", "SIXW" or the "Company") is pleased to provide an update on the development of it's Accelerated Molecular Imprinted Polymers (AMIPs™) and ongoing collaboration with York University.

Sixth Wave has successfully integrated its AMIP technology into a multicomponent microfluidic device with fluorescent detection. The prototype device, created by Dr. Pouya Rezai's and Dr. Satinder Brar's groups at York University, coats a thin layer of AMIPs polymer onto fluorescent magnetic microparticles. As the ultra-thin AMIP polymer shell binds the target pathogen, a change in the fluorescent signal is detected by the device. The integration of the detectors with microfluidics devices and "lab-on-a-chip" designs allow screening for multiple pathogens with a single test/device.

Keep reading... Show less
Sixth Wave Achieves Electrical Detection with AMIPs Technology

Sixth Wave Achieves Electrical Detection with AMIPs Technology

Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) ("Sixth Wave", "SIXW" or the "Company") is pleased to provide an update on the Company's Accelerated Molecular Imprinted Polymers (AMIPs™) and collaboration with York University.

Sixth Wave has successfully demonstrated the ability to identify the capture of pathogens electrically with one of its AMIPs prototypes. The prototype device created at York University integrates SIXW's AMIPs technology into an electrical sensor by coating the electrical sensor with AMIP polymer. When the AMIPs selectively binds with the target pathogen, a corresponding electrical signal is detected by the device.

Keep reading... Show less
Sixth Wave Announces Addition of Honorable Grant Mitchell to the Board of Directors

Sixth Wave Announces Addition of Honorable Grant Mitchell to the Board of Directors

Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) ("Sixth Wave" or the "Company") is pleased to announce that the Honourable Grant Mitchell will be joining the Company's Board of Directors effective immediately. Mr. Mitchell has been a valuable component of the Company's Strategic Advisory Board and is a welcome addition to the Board. This move comes as the Company continues to expand the independence and expertise represented in the Board.

Mr. Mitchell was appointed to the Senate of Canada in 2005 on the advice of Prime Minister Paul Martin and represented Alberta until his retirement in 2020. Prior to his appointment to the Senate, Mr. Mitchell spent twelve years serving in the Alberta Legislature as MLA, including four years as Opposition Leader from 1994 to 1998. More recently Mr. Mitchell has been intimately involved with both business and legislative policy around the environment, social, and governance (ESG), carbon tax/credits, and other similar initiatives.

Keep reading... Show less
The Power Play by The Market Herald Releases New Interviews with Universal Ibogaine and Hank Payments on Their Latest News

The Power Play by The Market Herald Releases New Interviews with Universal Ibogaine and Hank Payments on Their Latest News

The Power Play by The Market Herald has announced the release of new interviews with Universal Ibogaine and Hank Payments discussing their latest press releases

The Power Play by The Market Herald provides investors with a quick snapshot of what they need to know about the company's latest press release through exclusive insights and interviews with company executives.

Keep reading... Show less
Universal Ibogaine Announces Chief Clinics Officer Dr Ian Rabb

Universal Ibogaine Announces Chief Clinics Officer Dr Ian Rabb

Universal Ibogaine Inc. (TSXV: IBO) ("Universal Ibogaine", "UI" or the "Company"), a life sciences company with a mission to research and deliver medicalized ibogaine-centered addiction care, is pleased to announce an expansion of its Executive Team and welcomes addiction treatment and clinic operations veteran Dr Ian Rabb as Chief Clinics Officer effective November 15, 2021 .

Keep reading... Show less

Top News

Related News